clyne™Peptides
Peptide therapy

PT-141 (Bremelanotide)

PT-141 (Bremelanotide) — Clyne peptide therapy, prescription-only
← CatalogAvailable with a prescription

PT-141 (bremelanotide) is an FDA-approved active (Vyleesi). Prescription-only, physician-reviewed.

Route
subcutaneous injection
Format
Monthly subscription, provider-supervised
Baseline labs
Not typically required
Availability
Prescription-only after consultation

What to expect

You'll complete a medical intake and a licensed provider will review your history to decide whether PT-141 (Bremelanotide) is appropriate for you. Individual responses to peptide therapy vary, and there are no guaranteed outcomes — your provider monitors how you respond and adjusts or stops the plan as needed. To learn more about the science and current evidence, see the education profile.